Companies · Other
SAN FRANCISCO · CA, USA; Remote · Other · founded 2023 · http://www.getspect.com
Diligence memoA one-page analyst read on Spect Inc. — recommendation, valuation, rhythm, risks.→Spect Inc. looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Spect Inc. is one of 25008 Other companies tracked from SAN FRANCISCO, CA, USA; Remote, on record since 2023. By capital raised it ranks mid-pack (ahead of 45% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Value-based retinal screening in primary care to prevent blindness.
Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 25008 companies in Other. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 45% of sector peers (real $). Modeled value above 62% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #587 of 1,003.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Capture2, Inc. | Seed | $4.0M | $74.4M | 2.16× |
| Alliance Time Holdings, LLC | Seed | $4.0M | $74.4M | 2.16× |
| Nithio Holdings, Inc. | Seed | $4.0M | $74.4M | 2.16× |
| Springfield Hockey, LLC | Seed | $4.0M | $74.4M | 2.16× |
| Zooba Eats, Inc. | Seed | $4.0M | $74.4M | 2.16× |
| EQX Capital, Inc. | Seed | $4.0M | $74.4M | 2.16× |
| Chooze, Corp. | Seed | $4.0M | $74.4M | 2.16× |
| Spring Hill Development Partners, LLC | Seed | $8.0M | $74.4M | 2.16× |
| Equisphere Corp. | Seed | $4.0M | $74.4M | 2.16× |
| OHCP Northeastern Fiber Buyer Holdco, L.P. | Seed | $4.0M | $74.4M | 2.16× |
| Ontimeworks, Inc. | Seed | $6.0M | $74.4M | 2.16× |
| Polybio Capital, L.P. | Seed | $4.0M | $74.4M | 2.16× |
| Spect Inc. this company | Seed | $1.6M | $29.0M | 0.84× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $1.6M | 2017-08-22 | $7.8M | $29.0M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Ankur Gupta | — | 1 other | 2017-08 |
| Rishab Gargeya | — | — | 2017-08 |
| Theodore Leng | — | — | 2017-08 |
Spect Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Bulldog Innovation Group Llc | Other | Seed | $1.6M | $29.0M | same sector · same stage |
| GLOBAL TIN Corp | Other | Seed | $1.6M | $29.0M | same sector · same stage |
| NXT Water, Inc. | Other | Seed | $1.6M | $29.0M | same sector · same stage |
| Rsg5, Llc | Other | Seed | $1.6M | $29.0M | same sector · same stage |
| Ze-VO Technologies, LLC | Other | Seed | $1.6M | $29.0M | same sector · same stage |
| MedZed Holdings, LLC | Other | Seed | $1.6M | $29.0M | same sector · same stage |
| FormativeLearning, Inc. | Other | Seed | $1.6M | $29.0M | same sector · same stage |
| Natty Greene's Brewing Company, LLC | Other | Seed | $1.6M | $29.1M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Intelligent Retinal Imaging Systems, Inc. | AI / ML | Series A | $156.2M | 74% |
| RETINA-AI Health, Inc. | AI / ML | Series A | $40.9M | 71% |
| InVision Medical Technology AI Diagnosis of Heart Disease | Healthtech | — | — | 71% |
| O/D Vision, Inc. | Other Health Care | Pre-Seed | $3.4M | 71% |
| Adravision Automation for dental clinics and insurance companies. | Medical Devices | — | — | 69% |
| International Screening Solutions, Inc. | Other Technology | Seed | $63.4M | 69% |
| Sight Vision Partners, LLC | Hospitals and Physicians | Seed | $18.9M | 69% |
| Ocular Science, Inc. | Other Health Care | Pre-Seed | $5.4M | 69% |
See where Spect Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Spect Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.